Herpes zoster in patients with peptic ulcer disease: a plausible association?

In a recent paper Chen et al., using the longitudinal National Health Insurance Research of Taiwan database, compared 41 229 patients with peptic ulcer disease (PUD) and 41 229 matched controls. Because the cumulative incidence of varicella zoster infection in PUD patients was significantly higher compared with the control cohort (P < 0.001), the authors concluded that patients with PUD were at increased risk of herpes zoster (HZ) acquisition.1 Apparently, there is no consistent plausibility to support this conclusion. Herpesviridae is a large family of DNA viruses that can cause diseases in humans. At least four species of Herpesviridae [herpes simplex virus (HSV), varicella zoster virus (VZV), Epstein-Barr virus (EBV) and cytomegalovirus (CMV)] are documented to be widely spread among humans. The sites of latency are neurons for HSV and VZV, B cells for EBV and monocytes and lymphocytes for CMV. It is well-known that Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs (NSAIDs) and Herpesviridae are involved in the pathogenesis of PUD or gastric erosions.2 This family of viruses may be the cause of H. pylori-negative and NSAIDs-negative gastroduodenal lesions. Furthermore, VZV has been detected by polymerase chain reaction from endoscopic biopsy of subjects with common variable immunodeficiency.3 Nevertheless, it is difficult to prove the contrary. Chen et al. hypothesized that patients with PUD may be at a greater risk of varicella zoster infection due to their impaired cellular immunity and depressed nutritional status.4 However, there is no clear evidence that patients with PUD are immunocompromised. These patients are not more prone to infections than the general population.